[1] Reeves WH,Satoh M,Wang JS,et al.Antibodies to DNA,DNA-binding proteins and histones.Rheum Dis Clin North Am,1994,20:1-28. [2] Robertson CR,Gilkeson GS,Ward MM,et al.Patterns of heave and light chain utilization in the antibody response to single-sranded bacterial DNA in normal human subjects and patients with systemic lupus erythematosus.Clin Immunol Immunopathol,1992,62:25. [3] Liblau RS,Singer SM,McDevitt HO.Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune disease.Immunol Today,1995,16:34-38. [4] Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of theSLEDAI:a disease activity index for lupus patients.Arthritis Rheum,1992,35:630-640. [5] 杨景山主编.医学细胞化学与细胞生物技术.第1版.北京:北京医科大学、中国协和医科大学联合出版社,1990.6-17. [6] Chomczynski P,Sacchi N.Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction.Ann Biochem,1987,162:156-159. [7]金冬雁,黎孟枫等译.分子克隆实验指南.第1版.北京:科学出版社,1992.672-679. [8] Rangaraju M,Gray JD,Horwitz DA.Cytokine production in newly di-agnosed,untreated SLE patients:evidence for increased production of IL-10.Arthritis Rheum,1994,37(Suppl 9):1300. [9] Linker-Israeli M.Cytokine abnormalities in human lupus.Clin Immunol Immunopathol,1992,63:10-12. [10] Gerez L,Shkolnik T,Hirschmann O,et al.Hyperinducible expression of interferon-gamma gene and its suppression in systemic lupus erythemato-sus.Clin Exp Immunol,1997,109:296-303. |